Clinical Utility Of Mammaprint Testing In Invasive Lobular Carcinoma: Results From The Mindact Phase Iii Trial

O. Metzger,F. Cardoso, C. Poncet,C. Desmedt,S. Linn,J. Wesseling,F. Hilbers, K. Aalders,M. Delorenzi, S. Delaloge,J.Y. Pierga,E. Brain, S. Vrijaldenhoven, P.A. Neijenhuis,E. Rutgers,M. Piccart,L. van ’t Veer,G. Viale

EUROPEAN JOURNAL OF CANCER（2020）

引用 17|浏览115

暂无评分

摘要

Background: Chemotherapy-treatment (CT) decision for patients (pts) diagnosed with Invasive Lobular Carcinoma (ILC) remains controversial. We investigated the clinical utility of MammaPrint in pts diagnosed with early-stage ILC enrolled in MINDACT.

查看译文

关键词

mammaprint testing,invasive lobular carcinoma,mindact phase iii trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要